Cita APA (7a ed.)
Chen, P., Wang, M., Peng, S., Zhu, H., Wang, Y., Wan, Z., . . . Zhou, Y. (2026). Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma. Current Oncology, 31(3), 173-191.
Cita Chicago Style (17a ed.)
Chen, Ping, Mengchi Wang, Siyan Peng, Honglin Zhu, Yanming Wang, Zixuan Wan, Xuan Yang, Zhixin Yu, y Yixin Zhou. "Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma." Current Oncology 31, no. 3 (2026): 173-191.
Cita MLA (9a ed.)
Chen, Ping, et al. "Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma." Current Oncology, vol. 31, no. 3, 2026, pp. 173-191.
Precaución: Estas citas no son 100% exactas.